Gentian Diagnostics ASA (OSL:GENT)

Norway flag Norway · Delayed Price · Currency is NOK
55.00
-2.00 (-3.51%)
May 9, 2025, 4:26 PM CET
42.49%
Market Cap 848.23M
Revenue (ttm) 158.07M
Net Income (ttm) 48.89M
Shares Out 15.42M
EPS (ttm) 3.08
PE Ratio 17.87
Forward PE 34.12
Dividend 0.40 (0.70%)
Ex-Dividend Date May 7, 2025
Volume 61,702
Average Volume 16,412
Open 58.00
Previous Close 57.00
Day's Range 55.00 - 61.80
52-Week Range 36.60 - 61.80
Beta 0.28
RSI 63.19
Earnings Date May 7, 2025

About Gentian Diagnostics ASA

Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chro... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2001
Employees 63
Stock Exchange Oslo Børs
Ticker Symbol GENT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.